Waverley Pharma Inc.
WAVE.V
TSX
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 83.75% | 82.41% | 66.99% | 57.69% | -99.98% |
| Total Depreciation and Amortization | -3.25% | -60.49% | -82.02% | -92.75% | -74.20% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -88.65% | -92.89% | -88.30% | -85.69% | 9,987.01% |
| Change in Net Operating Assets | -196.53% | 89.85% | 156.16% | 338.95% | 407.18% |
| Cash from Operations | 43.67% | 76.21% | 57.68% | 60.38% | -8.57% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 65.98% | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 107.07% | -- | -- | -- | -168.56% |
| Total Debt Issued | -83.02% | -14.62% | 16.44% | 28.50% | 155.06% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -85.50% | -17.85% | 13.10% | 26.23% | 86.51% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -179.99% | 1,237.74% | 214.21% | 322.55% | 316.79% |